Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins
International Journal of Molecular Sciences (MDPI) plans a Special Issue: Recent Insights in Chemistry and Technology of Cyclodextrins in connection
Application of starch-based nanoparticles and cyclodextrin for prebiotics delivery and controlled glucose release in the human gut: a review
Starches are a major constituent of staple foods and are the main source of energy in the human diet (55-70%).
Tetraethylenepentamine-Coated β Cyclodextrin Nanoparticles for Dual DNA and siRNA Delivery
Tetraethylenepentamine-coated β-cyclodextrin (TEPA-BCD) nanoparticles were synthesized, characterized, and evaluated for targeted cell delivery of plasmid DNA and siRNA. The cationic
Brain uptake and distribution patterns of 2-hydroxypropyl-ß-cyclodextrin after intrathecal and intranasal administration
2-hydroxypropyl-ß-cyclodextrin (kleptose) is used for the treatment of Niemann–Pick disease. Kleptose crosses the blood–brain barrier poorly, in part because of
Enhanced Chiral Recognition Abilities of Cyclodextrin Covalent Organic Frameworks via Chiral/Achiral Functional Modification
β-Cyclodextrin covalent organic frameworks (β-CD COFs) show great potential in enantioseparation due to their uniformly distributed chiral recognition sites and
The role of deep eutectic solvents in chiral capillary electrokinetic chromatography: a comparative study based on α-cyclodextrin chiral selector
Deep eutectic solvents (DESs) are emerging as potential candidates as additives/modifiers in chiral electrokinetic chromatography (EKC). However, the true role
Poly(pseudo)rotaxanes formed by mixed micelles and α-cyclodextrin for drug delivery to the nail
This work aimed to develop water-based formulations for onychomycosis topical treatment using micelles of small pegylated surfactants associated with α-cyclodextrin
Insulin Complexation with Cyclodextrins—A Molecular Modeling Approach
Around 5% of the population of the world is affected with the disease called diabetes mellitus. The main medication of
Update: FDA approves HPBCD-enabled tecovirimat against pox virus
As reported earlier Siga Technologies filed a patent application in the USA describing cyclodextrin solubilized tecovirimat (ST-246). Tecovirimat has low
Life cycle of Tecovirimat authorized to treat human monkeypox infection in EU has been extended by reformulation with HPBCD by the originator Siga Technologies.
Tecovirimat SIGA (marketed under the trade name TPOXX® in USA) is an oral medicine to treat smallpox, monkeypox and cowpox,
pH-Responsive templates modulate the dynamic enzymatic synthesis of cyclodextrins
Product selection in the dynamic enzymatic synthesis of cyclodextrins can be controlled by changing the pH. Using cyclodextrin glucanotransferase to